Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibition
Meeting report with video, highlights and slides of a PACE-CME symposium held during ERA-EDTA 2018 in Copenhagen on the role of SGLT2 inhibition in Diabetic Kidney Disease.
Episodes 1-3 of 3
- Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibitionRemaining questions on SGLT2 inhibition & CKD: A review of new outcome trials
Prof. Colin Baigent
- Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibitionSGLT2 inhibition in kidney disease: key lessons from EMPA-REG OUTCOME
Prof. Christoph Wanner
- Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibitionUnderstanding CKD and SGLT2-inhibition: What are the key mechanisms?
Prof. Per-Henrik Groop
